## HWM: Howmet Aerospace Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -3.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($180.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Does Howmet Aerospace (NYSE:HWM) Have A Healthy Balance Sheet?**
- Source: 富途牛牛 | 20251208T140700 | Bullish | Relevance: 98%
- Howmet Aerospace Inc. (NYSE:HWM) has a healthy balance sheet, with its net debt at 1.1 times its EBITDA and its EBIT covering interest expenses 14.4 times over. The company's debt decreased to US$3.19 billion as of September 2025, and its EBIT grew by 31% over the last year. Howmet Aerospace also generated robust free cash flow, equating to 65% of its EBIT, indicating a strong ability to manage and reduce its debt.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | B of A Securiti | $250 | $215 | +16% |
| 2025-11-10 | JP Morgan | $227 | $190 | +19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | B of A Securiti | main | Buy |
| 2025-11-10 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.07M) |
| Sells | 1 ($0.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 14.3% (+80.7%)
- Vanguard Group Inc: 12.2% (+1.4%)
- Blackrock Inc.: 12.0% (+4.5%)
- State Street Corpora: 4.5% (+1.6%)
- FMR, LLC: 4.0% (+2.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.80 indicates undervaluation relative to growth. Forward P/E 43.2x stretched relative to 20% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 18%). Balance sheet: strong liquidity (2.4x). Analyst sentiment positive (2 raises, avg +18%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $77.0B |
| Beta | 1.32 |
| 52W Range | $105.04 - $211.95 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.80 |
| Forward P/E | 43.2 |
| Current P/E | 51.8 |
| YoY Growth | 20.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -4.9% to -3.9% (+1.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.8pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.12x) but short-term weakness (below SMA20). MACD histogram bearish (-1.42), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.85% (CS: 15) | Weak |
| RSI_14 | 39.6 | Neutral |
| MACD Histogram | -1.42 | Bearish |
| vs SMA20 | 0.959x | Below |
| vs SMA50 | 0.966x | Below |
| vs SMA200 | 1.121x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $191.36
- **Stop Loss:** $180.32 (5.8% risk)
- **Target:** $202.40 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 45
- **Position Value:** $8,611.20
- **Portfolio %:** 8.61%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-12 (Est: $0.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.91 | $0.95 | +4.5% |
| 2025Q2 | $0.87 | $0.91 | +4.2% |
| 2025Q1 | $0.78 | $0.86 | +10.7% |
| 2024Q4 | $0.72 | $0.74 | +2.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*